Kirklin JK - Search Results

1

Patterns and predictors of physical functional disability at 5 to 10 years after heart transplantation.

Grady KL, Naftel DC, Young JB, Pelegrin D, Czerr J, Higgins R, Heroux A, Rybarczyk B, McLeod M, Kobashigawa J, Chait J, White-Williams C, Myers S, Kirklin JK. Grady KL, et al. Among authors: kirklin jk. J Heart Lung Transplant. 2007 Nov;26(11):1182-91. doi: 10.1016/j.healun.2007.08.001. Epub 2007 Sep 27. J Heart Lung Transplant. 2007. PMID: 18022086 Free PMC article.

2

Total lymphoid irradiation in the treatment of early or recurrent heart rejection.

Salter MM, Kirklin JK, Bourge RC, Naftel DC, White-Williams C, Tarkka M, Waits E, Bucy RP. Salter MM, et al. Among authors: kirklin jk. J Heart Lung Transplant. 1992 Sep-Oct;11(5):902-11; discussion 911-2. J Heart Lung Transplant. 1992. PMID: 1420238 Clinical Trial.

3

Rejection after cardiac transplantation. A time-related risk factor analysis.

Kirklin JK, Naftel DC, Bourge RC, White-Williams C, Caulfield JB, Tarkka MR, Holman WL, Zorn GL Jr. Kirklin JK, et al. Circulation. 1992 Nov;86(5 Suppl):II236-41. Circulation. 1992. PMID: 1424006

4

Methotrexate pulse therapy in the treatment of recurrent acute heart rejection.

Bourge RC, Kirklin JK, White-Williams C, Naftel DC, George JF, Morrow R, Tarkka M, Welborn JM. Bourge RC, et al. Among authors: kirklin jk. J Heart Lung Transplant. 1992 Nov-Dec;11(6):1116-24. J Heart Lung Transplant. 1992. PMID: 1457434

5

Cyclosporine blood monitoring after heart transplantation: a prospective comparison of monoclonal and polyclonal radioimmunoassays.

Bourge RC, Kirklin JK, Ketchum C, Naftel DC, Mason DA, Siegel AL, Scott JW, White-Williams C. Bourge RC, et al. Among authors: kirklin jk. J Heart Lung Transplant. 1992 May-Jun;11(3 Pt 1):522-9. J Heart Lung Transplant. 1992. PMID: 1610859

6

Analysis and predictors of pulmonary vascular resistance after cardiac transplantation.

Bourge RC, Kirklin JK, Naftel DC, White C, Mason DA, Epstein AE. Bourge RC, et al. Among authors: kirklin jk. J Thorac Cardiovasc Surg. 1991 Mar;101(3):432-44; discussion 444-5. J Thorac Cardiovasc Surg. 1991. PMID: 1999936

7

Diltiazem-cyclosporine interaction in cardiac transplant recipients: impact on cyclosporine dose and medication costs.

Bourge RC, Kirklin JK, Naftel DC, Figg WD, White-Williams C, Ketchum C. Bourge RC, et al. Among authors: kirklin jk. Am J Med. 1991 Mar;90(3):402-4. Am J Med. 1991. PMID: 2003525 No abstract available.

8

Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.

Kirklin JK, Bourge RC, White-Williams C, Naftel DC, Thomas FT, Thomas JM, Phillips MG. Kirklin JK, et al. J Thorac Cardiovasc Surg. 1990 Apr;99(4):716-24. J Thorac Cardiovasc Surg. 1990. PMID: 2108282

9

Pulmonary vascular resistance and the risk of heart transplantation.

Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Kirklin JK, et al. Among authors: kirklin jw. J Heart Transplant. 1988 Sep-Oct;7(5):331-6. J Heart Transplant. 1988. PMID: 3058901

10

Risk factors for death and related events after cardiac transplantation.

Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH. Kirklin JK, et al. Among authors: kirklin jw. Adv Cardiol. 1988;36:278-92. doi: 10.1159/000415645. Adv Cardiol. 1988. PMID: 3071104 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

645 results

Search Page

Filters